Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma

被引：16
|
作者：
Greenberg, A. J. [1 ]
Lee, A. M. [2 ]
Serie, D. J. [3 ]
McDonnell, S. K. [3 ]
Cerhan, J. R. [1 ]
Liebow, M. [4 ]
Larson, D. R. [3 ]
Colby, C. L. [3 ]
Norman, A. D. [3 ]
Kyle, R. A. [5 ]
Kumar, S. [5 ]
Rajkumar, S. V. [5 ]
Diasio, R. B. [2 ]
Slager, S. L. [3 ]
Vachon, C. M. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA
[3] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA
[4] Mayo Clin, Coll Med, Dept Internal Med, Div Gen Internal Med, Rochester, MN USA
[5] Mayo Clin, Coll Med, Dept Internal Med, Div Hematol, Rochester, MN USA
来源：
LEUKEMIA | 2013年 / 27卷 / 02期
关键词：
BLOOD-PRESSURE; RISK; POPULATION;
D O I：
10.1038/leu.2012.232
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：515 / 516
页数：2
相关论文
共 50 条
  • [21] Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma
    Thomas, Sheeba K.
    Suvorov, Alexander
    Noens, Lucien
    Rukavitsin, Oleg
    Fay, Joseph
    Wu, Ka Lung
    Zimmerman, Todd M.
    van de Velde, Helgi
    Bandekar, Rajesh
    Puchalski, Thomas A.
    Qi, Ming
    Uhlar, Clarissa
    Samoylova, Olga S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 35 - 42
  • [22] Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
    Chang, Su-Hsin
    Gumbel, Jason
    Luo, Suhong
    Thomas, Theodore S.
    Sanfilippo, Kristen M.
    Luo, Jingqin
    Colditz, Graham A.
    Carson, Kenneth R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (12) : 2055 - 2061
  • [23] Multiparameter Flow Cytometry Identification of Neoplastic Subclones: A New Biomarker in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
    Tarin, Fabian
    Lopez-Castano, Francisco
    Garcia-Hernandez, Carmen
    Beneit, Paola
    Sarmiento, Hector
    Manresa, Pablo
    Alda, Olga
    Villarrubia, Blanca
    Blanes, Margarita
    Bernabeu, Javier
    Amoros, Carmen
    Sanchez-Sanchez, Sara
    Fernandez-Minano, Carmen
    De Paz, Francisco
    Verdu-Belmar, Jose
    Marco, Pascual
    Matutes, Estella
    ACTA HAEMATOLOGICA, 2019, 141 (01) : 1 - 6
  • [24] The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
    Mikulasova, Aneta
    Wardell, Christopher P.
    Murison, Alexander
    Boyle, Eileen M.
    Jackson, Graham H.
    Smetana, Jan
    Kufova, Zuzana
    Pour, Ludek
    Sandecka, Viera
    Almasi, Martina
    Vsianska, Pavla
    Gregora, Evzen
    Kuglik, Petr
    Hajek, Roman
    Davies, Faith E.
    Morgan, Gareth J.
    Walker, Brian A.
    HAEMATOLOGICA, 2017, 102 (09) : 1617 - 1625
  • [25] Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis
    Landgren, O.
    Weiss, B. M.
    LEUKEMIA, 2009, 23 (10) : 1691 - 1697
  • [26] Associations Between Patient Characteristics and Progression to Multiple Myeloma Among Patients With Monoclonal Gammopathy of Undetermined Significance: A Systematic Review
    Li, Yimeng
    Hsu, Sylvia H.
    Wang, Rong
    Theprungsirikul, Poy
    Neparidze, Natalia
    Chang, Su-Hsin
    Wang, Shi-Yi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (04) : e222 - e231
  • [27] SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Schmidt, Timothy
    Gahvari, Zhubin
    Callander, Natalie S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10) : 653 - 664
  • [28] Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
    Gran, Charlotte
    Liwing, Johan
    Wagner, Arnika Kathleen
    Verhoek, Andre
    Gezin, Ana
    Alici, Evren
    Nahi, Hareth
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (01) : 23 - 30
  • [29] The clinical features and prognosis of the monoclonal gammopathy undetermined significance: A single center study
    Ma, Ling
    Xu, Shuang
    Wen, Lei
    Liu, Yang
    Kan, Ying
    Huang, Xiaojun
    Lu, Jin
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 73 : 9 - 13
  • [30] Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima
    Fujimura, Kingo
    Sugiyama, Aya
    Akita, Tomoyuki
    Ohisa, Masayuki
    Nagashima, Shintaro
    Katayama, Keiko
    Maeda, Ryo
    Tanaka, Junko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (04) : 576 - 585
12345